Public companies that invest in their people have three times’ the return on their stock price of those that don’t, making a clear case for investing in plan members’ health needs and disability prevention strategies, said Tyler Amell, adjunct faculty at Pacific Coast University for Workplace Health Sciences, during Benefits Canada’s 2021 Chronic Disease at […]
Private drug plan spending increased 5.4 per cent, according to Express Scripts Canada’s annual drug trends report. While up to a one per cent increase in private drug plan spending was anticipated, similar to the 0.6 per cent increase between 2018 to 2019; the report showed a decrease in the percentage of members who claimed, […]
High-cost drugs remain the primary cost driver for Canadian public and private drug plans, said the Patented Medicine Prices Review Board’s newly released 2019 annual report. Patty Hajdu, the federal government’s minister of health, tabled the report, which found the sales of patented drugs grew 3.5 per cent to over $17 billion in 2019. Additionally, […]
Growth in chronic disease and increased drug claims are two of the key factors driving up the cost of private health benefit plans, according to a new report by Innovative Medicines Canada. It found that chronic diseases accounted for 68 per cent of drug plan claims costs and 79 per cent of growth. Claims costs […]
The mental-health impacts of isolation and quarantine are clear, but Canadians may not realize loneliness can also harm their physical health, said Diane McIntosh, psychiatrist and chief neuroscience officer at Telus Health, during Benefits Canada’s 2020 Mental Health Summit on Nov. 12. “There have been correlates that loneliness or isolation . . . is like […]
The costs of employer-provided health plans in Canada are expected to rise seven per cent next year, outpacing general inflation by more than five per cent, according to a new report by Aon Canada. Contributing factors include higher drug prices, the impact of non-communicable health risks and the continued introduction of new and expensive therapies. Indeed, […]
As the coronavirus pandemic spread across the world, employee health came into sharp relief. Employers took action to provide creative solutions to ensure staff remained healthy, with the quick implementation of virtual programs to allow plan members easy access to health-care professionals through online channels. That same solutions-based attitude of adaptability is useful when considering […]
Toronto-based disease prevention technology company Newtopia Inc. is introducing a product suite aimed at preventing, reversing and slowing the progression of three chronic conditions. Targeting plan members of employer-sponsored health plans, the tools aim to assist users with hypertension, type 2 diabetes and weight management. They combine human interaction, virtual care, digital tools and data science to deliver personalized […]
The Newfoundland and Labrador Court of Appeal has found a labour arbitrator failed to properly analyze an employer’s efforts to accommodate an employee taking medical cannabis for his chronic pain. The International Brotherhood of Electrical Workers initially filed a grievance on behalf of one of its members, who was refused employment by Valard Construction for […]
Employers are increasingly interested in seeing more support for chronic disease and chronic pain management in their benefits plans, according to the 2020 Sanofi Canada health-care survey. The vast majority (88 per cent) of plan sponsors said they want their health benefits plan to do more to support plan members living with chronic diseases, up from 82 […]